Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7

Abstract

Chemotactic cytokines (chemokines) attract immune cells, although their original evolutionary role may relate more closely with embryonic development. We noted differential expression of the chemokine receptor CXCR7 (RDC-1) on marginal zone B cells, a cell type associated with autoimmune diseases. We generated Cxcr7 ؊/؊ mice but found that CXCR7 deficiency had little effect on B cell composition. However, most Cxcr7 ؊/؊ mice died at birth with ventricular septal defects and semilunar heart valve malformation. Conditional deletion of Cxcr7 in endothelium, using Tie2-Cre transgenic mice, recapitulated this phenotype. Gene profiling of Cxcr7 ؊/؊ heart valve leaflets revealed a defect in the expression of factors essential for valve formation, vessel protection, or endothelial cell growth and survival. We confirmed that the principal chemokine ligand for CXCR7 was CXCL12/SDF-1, which also binds CXCR4. CXCL12 did not induce signaling through CXCR7; however, CXCR7 formed functional heterodimers with CXCR4 and enhanced CXCL12-induced signaling. Our results reveal a specialized role for CXCR7 in endothelial biology and valve development and highlight the distinct developmental role of evolutionary conserved chemokine receptors such as CXCR7 and CXCR4.chemokines ͉ heart ͉ heterodimerization ͉ immunology ͉ endothelium

β-arrestin control of late endosomal sorting facilitates decoy receptor function and chemokine gradient formation

“…Cxcr7 function is important for heart development (Sierro et al, 2007), interneuron migration (Sánchez-Alcañiz et al, 2011;Wang et al, 2011), leukocyte trafficking (Cruz-Orengo et al, 2011) and for promoting breast and lung tumorigenesis (Miao et al, 2007;Luker et al, 2012). Some of these in vivo studies, as well as those conducted in vitro (Luker et al, 2010;Naumann et al, 2010), are consistent with the idea that Cxcr7 serves as a receptor that effectively scavenges Cxcl12a and does not influence downstream signaling pathways (reviewed by Mantovani et al, 2006).…”

CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers

“…[9][10][11][12] More recently, CXCR7 has been described as an alternate receptor for CXCL12, which appears to function by sequestering CXCL12 13 and modifying CXCR4 signaling rather than displaying autonomous signaling in response to CXCL12. 14 Mesenchymal stromal cells (MSCs) are considered a major source for CXCL12 in the adult organism. CXCL12-secreting stromal cells can be found in various tissues, such as the liver, lungs, lymphatic tissues and the marrow.…”

CXCR4 signaling in the regulation of stem cell migration and development

“…The full extent of the importance of CXCR7 signaling in development and adult function remains to be determined. (Miao et al, 2007;Sierro et al, 2007;Valentin et al, 2007).…”